gp100 antigen
Term · Oncology and biomedicine · MLC-T-ONC-014016
A melanoma-associated antigen. When administered in a vaccine formulation, gp100 antigen may stimulate a cytotoxic T cell HLA-A2.1-restricted immune response against tumors that express this antigen, which may result in a reduction in tumor size.
| Identifier | MLC-T-ONC-014016 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | gp100 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-014016",
"term": "gp100 antigen",
"field": "Oncology and biomedicine",
"definition": "A melanoma-associated antigen. When administered in a vaccine formulation, gp100 antigen may stimulate a cytotoxic T cell HLA-A2.1-restricted immune response against tumors that express this antigen, which may result in a reduction in tumor size.",
"synonyms": [
"gp100"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/gp100-antigen/"
}
Record 8,142 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.